Asri Karya Lestari Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Asri Karya Lestari Tbk. trades at Rp210 (market cap 1.22T, 25.66M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Asri Karya Lestari Tbk. is far larger — about 7.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Asri Karya Lestari Tbk. is more actively traded (25.66M versus 62.5K). Which is the better fit depends on your goals.
| ASLI | OBAT | |
|---|---|---|
Market Cap | 1.22T | 164.65B |
Volume | 25.66M | 62.5K |
Lot | 256.58K | 625 |
Turnover | 5.39B | 15.03M |
Average Price | 210.23 | 240.55 |
Value | 5.39B | 15.03M |
Indicative Equilibrium Price | 210 | 238 |
Indicative Equilibrium Volume | 4.18K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Asri Karya Lestari Tbk (‘the Entity’) was established as a limited liability company based on deed No. 05 on December 20, 2008 before Notary Syanti Hardiyanti, SH in Jakarta. The entity started its commercial operations in 2009
Read more on ASLI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →